[1] |
Mirabello L, Clarke MA, Nelson CW , et al. The intersection of HPV epidemiology, genomics and mechanistic studies of HPV-mediated carcinogenesis[J]. Viruses, 2018,10(2):80. doi: 10.3390/v10020080.
DOI
URL
|
[2] |
Hoppe-Seyler K, Bossler F, Braun JA , et al. The HPV E6/E7 Oncogenes: key factors for viral carcinogenesis and therapeutic targets[J]. Trends Microbiol, 2018,26(2):158-168. doi: 10.1016/j.tim.2017.07.007.
DOI
URL
PMID
|
[3] |
Scheffner M, Werness BA Huibregtse JM , et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53[J]. Cell, 1990,63(6):1129-1136. doi: 10.1016/0092-8674(90)90409-8.
DOI
URL
PMID
|
[4] |
Taberna M, Mena M, Pavón MA , et al. Human papillomavirus-related oropharyngeal cancer[J]. Ann Oncol, 2017,28(10):2386-2398. doi: 10.1093/annonc/mdx304.
DOI
URL
PMID
|
[5] |
Götz C, Bischof C, Wolff KD , et al. Detection of HPV infection in head and neck cancers: promise and pitfalls in the last ten years: a meta-analysis[J]. Mol Clin Oncol, 2019,10(1):17-28. doi: 10.3892/mco.2018.1749.
DOI
URL
PMID
|
[6] |
Senkomago V, Henley SJ, Thomas CC , et al. Human papillomavirus-attributable cancers-united states, 2012-2016[J]. MMWR Morb Mortal Wkly Rep, 2019,68(33):724-728. doi: 10.15585/mmwr.mm6833a3.
DOI
URL
PMID
|
[7] |
Amin MB, Greene FL, Edge SB , et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging[J]. CA Cancer J Clin, 2017,67(2):93-99. doi: 10.3322/caac.21388.
DOI
URL
PMID
|
[8] |
Prevc A, Kranjc S, Cemazar M , et al. Dose-modifying factor of radiation therapy with concurrent cisplatin treatment in HPV-positive squamous cell carcinoma: a preclinical study[J]. Radiat Res, 2018,189(6):644-651. doi: 10.1667/RR14984.1.
DOI
URL
PMID
|
[9] |
Singh RD, Patel KR, Patel PS . "p53 mutation spectrum and its role in prognosis of oral cancer patients: a study from Gujarat, West India"[J]. Mut Res, 2016,783:15-26. doi: 10.1016/j.mrfmmm.2015.12.001.
|
[10] |
Zhou G, Liu Z, Myers JN . TP53 mutations in head and neck squamous cell carcinoma and their impact on disease progression and treatment response[J]. J Cell Biochem, 2016,117(12):2682-2692. doi: 10.1002/jcb.25592.
DOI
URL
PMID
|
[11] |
Liu C, Mann D, Sinha UK , et al. The molecular mechanisms of increased radiosensitivity of HPV-positive oropharyngeal squamous cell carcinoma (OPSCC): an extensive review[J]. J Otolaryngol Head Neck Surg, 2018,47(1):59. doi: 10.1186/s40463-018-0302-y.
DOI
URL
PMID
|
[12] |
Wang H, Wang B, Wei J , et al. Molecular mechanisms underlying increased radiosensitivity in human papillomavirus-associated oropharyngeal squamous cell carcinoma[J]. Int J Biol Sci, 2020,16(6):1035-1043. doi: 10.7150/ijbs.40880.
DOI
URL
PMID
|
[13] |
Steve, Seltzsam, Frank , et al. In HPV-positive HNSCC cells, functional restoration of the p53/p21 pathway by proteasome inhibitor bortezomib does not affect radio- or chemosensitivity[J]. Transl Oncol, 2019,12(3):417-25. doi: 10.1016/j.tranon.2018.11.013.
DOI
URL
PMID
|
[14] |
Barnes RP, Fouquerel E, Opresko PL . The impact of oxidative DNA damage and stress on telomere homeostasis[J]. Mech Ageing Dev, 2018,177:37-45. doi: 10.1016/j.mad.2018.03.013.
DOI
URL
PMID
|
[15] |
Vitti ET, Parsons JL . The radiobiological effects of proton beam therapy: impact on DNA damage and repair[J]. Cancers(Basel), 2019,11(7):946. doi: 10.3390/cancers11070946.
|
[16] |
Piazza A, Heyer WD . Homologous recombination and the formation of complex genomic rearrangements[J]. Trends Cell Biol, 2019,29(2):135-149. doi: 10.1016/j.tcb.2018.10.006.
DOI
URL
PMID
|
[17] |
Chang HHY, Pannunzio NR, Adachi N , et al. Non-homologous DNA end joining and alternative pathways to double-strand break repair[J]. Nat Rev Mol Cell Biol, 2017,18(8):495-506. doi: 10.1038/nrm.2017.48.
DOI
URL
PMID
|
[18] |
Wieringa HW, van der Zee AG, de Vries EG , et al. Breaking the DNA damage response to improve cervical cancer treatment[J]. Cancer Treat Rev, 2016,42:30-40. doi: 10.1016/j.ctrv.2015. 11.008.
DOI
URL
PMID
|
[19] |
Lyu X, Zhang M, Li G , et al. PD-1 and PD-L1 expression predicts radiosensitivity and clinical outcomes in head and neck cancer and is associated with HPV infection[J]. J Cancer, 2019,10(4):937-948. doi: 10.7150/jca.27199.
DOI
URL
PMID
|
[20] |
Rödel F, Martin D, Balermpas P , et al. Modulation of radiation sensitivity and antitumor immunity by viral pathogenic factors: implications for radio-immunotherapy[J]. Biochim Biophys Acta Rev Cancer, 2019,1871(1):126-137. doi: 10.1016/j.bbcan.2018. 12.006.
DOI
URL
PMID
|
[21] |
Kim HS, Lee JY, Lim SH , et al. Association between PD-L1 and HPV status and the prognostic value of PD-L1 in oropharyngeal squamous cell carcinoma[J]. Cancer Res Treat, 2016; 48(2):527-536. doi: 10.4143/crt.2015.249.
DOI
URL
PMID
|
[22] |
Seiwert TY, Burtness B, Mehra R , et al. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial[J]. Lancet Oncol, 2016,17(7):956-965. doi: 10.1016/S1470-2045(16)30066-3.
DOI
URL
PMID
|